Stocks Health care MRVI
NASDAQ · Health careMaravai Lifesciences Holdings, Inc. (MRVI)
Maravai Lifesciences Holdings, Inc. brought in $208.8M of revenue over the twelve months to June 30, 2026, down 5.0% from a year earlier. It posted a net loss of $77.4M. In fiscal 2025 capital spending exceeded operating cash flow by $70.7M. At June 30, 2026 it held $70.1M in cash against $147.1M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 7, 2026.
What Maravai Lifesciences Holdings, Inc. does
Maravai Lifesciences Holdings, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker MRVI.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $185.7M | -$130.8M | -$0.90 | -$70.7M |
| 2024 | $259.2M | -$144.8M | -$1.05 | -$22.2M |
| 2023 | $288.9M | -$119M | -$0.90 | $60.7M |
| 2022 | $883M | $220.2M | $1.67 | $518.9M |
| 2021 | $799.2M | $182M | $1.56 | $353.7M |
| 2021 | $284.1M | $89M | $2.36 | $126.8M |
Latest SEC filings
What Maravai Lifesciences Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- August 7, 2026Quarterly report 10-Q · period to June 30, 2026
- August 6, 2026
- June 29, 2026Passive stake (5% or more) SCHEDULE 13G
- June 23, 2026Passive stake (5% or more) SCHEDULE 13G
- June 3, 2026
- May 29, 2026
- May 15, 2026Passive stake changed SCHEDULE 13G/A
- May 14, 2026Passive stake changed SCHEDULE 13G/A
- May 12, 2026Passive stake (5% or more) SCHEDULE 13G
Questions about MRVI
What does Maravai Lifesciences Holdings, Inc. do?
Maravai Lifesciences Holdings, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker MRVI.
Is Maravai Lifesciences Holdings, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $77.4M on revenue of $208.8M.
How much revenue does Maravai Lifesciences Holdings, Inc. make?
Over the twelve months to June 30, 2026 Maravai Lifesciences Holdings, Inc. reported revenue of $208.8M. That is 5.0% less than a year earlier.
When did Maravai Lifesciences Holdings, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 7, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 9, 2026.
Similar companies
Follow MRVI
Get an email when Maravai Lifesciences Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow MRVI: get an email when it filesWhere the numbers come from
Financial figures are the values Maravai Lifesciences Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.